1-6 of 6
t-cell therapy
Close
Sort by
Journal Articles

Developing T-cell therapies for lymphoma without receptor engineering

Melanie Grant, Catherine M. Bollard
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 622–631.
https://doi.org/10.1182/asheducation-2017.1.622
Published: 2017
Journal Articles

Primary mediastinal B-cell lymphoma: biology and evolving therapeutic strategies

Kieron Dunleavy
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 298–303.
https://doi.org/10.1182/asheducation-2017.1.298
Published: 2017
Journal Articles

Emerging options in multiple myeloma: targeted, immune, and epigenetic therapies

Shaji Kumar
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 518–524.
https://doi.org/10.1182/asheducation-2017.1.518
Published: 2017
Journal Articles

Cytotoxic T lymphocytes for leukemia and lymphoma

Catherine M. Bollard, A. John Barrett
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 565–569.
https://doi.org/10.1182/asheducation-2014.1.565
Published: 2014
Journal Articles

T-cell therapy for viral infections

Helen E. Heslop, Ann M. Leen
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 342–347.
https://doi.org/10.1182/asheducation-2013.1.342
Published: 2013
Journal Articles

Engineering Antitumor Immunity by T-Cell Adoptive Immunotherapy

Stanley R. Riddell
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 250–256.
https://doi.org/10.1182/asheducation-2007.1.250
Published: 2007